👀 Ones to watch: Undervalued stocks to buy before they report Q3 earningsSee Undervalued Stocks

Oracle shares price target raised by HSBC on cloud growth prospects

EditorTanya Mishra
Published 10/11/2024, 06:11 AM
ORCL
-

An HSBC analyst increased the price target for Oracle Corporation (NYSE: NYSE:ORCL) shares to $180 from $166 while reiterating a "Buy" rating.

The adjustment reflects the analyst's expectation that Oracle's revenue growth will consistently reach double digits. This forecast is based on the strong performance and cost-efficiency of Oracle Cloud Infrastructure (OCI), which is gaining market share.

The analyst highlighted that a significant portion of global IT spending remains on-premise, indicating a substantial growth opportunity for cloud services providers.

With more than 80% of IT expenditures still outside the cloud, the transition to cloud-based solutions is anticipated to provide a lengthy period of expansion for the industry. Furthermore, advancements in artificial intelligence (AI) are expected to further boost demand for cloud services.

Oracle has indicated that its capital expenditure for the fiscal year 2025 is likely to be double that of fiscal year 2024. The company's strategy aligns with other major cloud service providers, preparing for the anticipated surge in demand for cloud Infrastructure-as-a-Service (IaaS) driven by the global AI buildout.

Despite the anticipated increase in spending, HSBC projects that Oracle's non-GAAP operating margin will improve. By the fiscal year 2028, the margin is expected to rise to 46.2%, up from 43.5% in fiscal year 2024.

In other recent news, Oracle Corporation has seen several significant developments. The company received an upgrade from Erste Group, shifting its rating from Hold to Buy, citing robust software offerings and an expanding cloud infrastructure.

Oracle's sales and profits are projected to see substantial growth in the current and upcoming fiscal year, which is expected to contribute to an increase in its operating margin.

Oracle has also issued $6.25 billion in senior notes, with the net proceeds planned for debt repayment and potential future acquisitions. The issuance involved major financial institutions, such as BofA Securities and Goldman Sachs & Co. In addition, Oracle Health introduced significant updates to its electronic health record system, aiming to improve efficiency and patient care.

Furthermore, Oracle has launched Java 23, featuring several enhancements aimed at boosting developer productivity. The company's strategic advancements in cloud services and database management are expected to enhance its market position and drive revenue growth.

InvestingPro Insights

Oracle's strong market position and growth potential, as highlighted in the article, are further supported by recent InvestingPro data. The company's market capitalization stands at an impressive $486.07 billion, reflecting its significant presence in the software industry. Oracle's revenue for the last twelve months reached $53.81 billion, with a notable revenue growth of 5.6%, aligning with the analyst's positive outlook on the company's future performance.

InvestingPro Tips reveal that Oracle has maintained dividend payments for 16 consecutive years and has raised its dividend for 11 consecutive years, demonstrating a commitment to shareholder returns. This consistent dividend policy complements the company's strong financial performance and growth prospects in the cloud services market.

The stock's recent performance has been remarkable, with a 61.94% total return over the past year and a 68.41% return year-to-date. This aligns with the analyst's bullish stance and increased price target. However, investors should note that the stock is trading near its 52-week high, with a price at 98.21% of its 52-week high value.

For those interested in a deeper analysis, InvestingPro offers 20 additional tips for Oracle, providing a comprehensive view of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.